|
|
| Kernkompetenz
- Übersicht |
|
We present our main fields of Core Competence
1. key words: Nuclear Medicine, PET, Positron ( )?e Emission Tomography
Construction and installation services for PET and Nuclear Medicine
We offer to build up the following structures:
1.1. Pharmaceutical
Pharmaceutical production site for radioactive pharmaceuticals based on cyclotron and hot and cold clean room production rooms.
Distribution concepts for short term living Fluorine-18 based pharmaceuticals, including charter plane concepts (see:IASON PET Network Europe).
Tools for the implementation of G.M.P. (Good Manufacturing Practice).
Documentation for the new site.
Tools for the implementation of Radiation safety measures at the new site.
Tools for the implementation of hygiene and pharmaceutical safety standards at the new site.
1.2. Medical
Nuclear medicine unit for Positron Emission Tomography.
Nuclear medicine treatment unit for Nuclide based antibody therapy.
Scintigraphy units according to your local needs.
ALL Products, Installations and Tools meet the latest standards in the field.
Our services are conducted in cooperation with one of the most famous European Universities, as such, we are able to implement the most advanced standards at installation sites.
Fields of patient care:
Oncology: Early diagnosis of all type of cancers, Follow up, treatment planning.
Neurology: Diagnosis of Epileptic foci, surgery planning
Cardiology: Diagnosis of vital zones after heart stroke, planning of bypass intervention
and others
Investment Volumes: 6.000.000 - 12 .000.000 Mio. € (4-10 Bio. US $) per site
2. key words: RIA, Radio Immunoassay, ELISA, Enzyme Immuno Assay,
Laboratory, Thyroid Antibodies, Thyroglobuline, Thyroid Cancer, Diabetes Diagnosis,
Highly sensitive Immunoassays for the serologic determination of Thyroglobuline and autoantobodies to thyrogl obuline and thyroidal peroxidase
Highly sensitive immunoassays for the serologic determination of autoantibodies for the early prediction of Type I Diabetes in follow up of Type II Diabetes; early detection of usefulness of prescription of Insulin.
Investment Volumes/ annual consumption: 300.000 - 500.000 € for a major treatment hospital for Thyroid Special Diseases or Diabetes Diseases.
|
| |
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
